Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of three common receptors: estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor 2 (HER2) (33, 34). This evidence concerns the gene PGR and triple-negative breast carcinoma.